XML 45 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Accounting for the Transaction Accounting for the Transaction - Additional Information (Details)
$ in Thousands
12 Months Ended
Apr. 12, 2019
USD ($)
shares
Dec. 31, 2019
USD ($)
Jun. 30, 2020
USD ($)
Apr. 11, 2019
Business Acquisition [Line Items]        
Goodwill   $ 32,970 $ 32,970  
Non-cash charges   7,500    
Immunic, Inc.        
Business Acquisition [Line Items]        
Incurred costs   $ 10,000    
Immunic AG        
Business Acquisition [Line Items]        
Percentage of shares owned 88.25%      
Immunic AG | Vital Therapies, Inc.        
Business Acquisition [Line Items]        
Exchange ratio       17.17
Vital Therapies, Inc.        
Business Acquisition [Line Items]        
Percentage of shares owned 11.75%      
Vital Therapies, Inc. | Immunic, Inc.        
Business Acquisition [Line Items]        
Goodwill $ 32,970      
Outstanding stock options        
Business Acquisition [Line Items]        
Outstanding shares to purchase (in shares) | shares 16,987      
Restricted Stock Units        
Business Acquisition [Line Items]        
Outstanding shares to purchase (in shares) | shares 127,500